Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,385,171 papers from all fields of science
Search
Sign In
Create Free Account
SR 142948A
Known as:
SR-142948A
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Adamantane
Imidazoles
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Selectively increased trace conditioning under the neurotensin agonist PD 149163 in an aversive procedure in which SR 142948A was without intrinsic effect
S. Grimond-Billa
,
C. Norman
,
Geoffrey W. Bennett
,
H. Cassaday
Journal of Psychopharmacology
2008
Corpus ID: 28106841
There is evidence to suggest that neurotensin (NT) may enhance cognitive function. The present study, therefore, examined the…
Expand
Highly Cited
2005
Highly Cited
2005
Endogenous Neurotensin in the Ventral Tegmental Area Contributes to Amphetamine Behavioral Sensitization
F. Panayi
,
J. Colussi-Mas
,
L. Lambás-señas
,
B. Renaud
,
H. Scarna
,
A. Bérod
Neuropsychopharmacology
2005
Corpus ID: 22438400
Studies showing psychostimulant-like effects of exogenous neurotensin (NT) infused into the ventral tegmental area (VTA) prompted…
Expand
2002
2002
The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area
M. Leonetti
,
P. Brun
,
+5 authors
M. Suaud-Chagny
Naunyn-Schmiedeberg's Archives of Pharmacology
2002
Corpus ID: 2934039
Abstract. The neuropeptide neurotensin (NT) exerts a wide range of central and peripheral effects. In particular, ejection of NT…
Expand
1998
1998
Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain.
C. Betancur
,
M. Canton
,
+4 authors
D. Pélaprat
European Journal of Pharmacology
1998
Corpus ID: 3500447
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required